Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended	9 Months Ended
	Jul. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Jun. 30, 2023	Sep. 30, 2023	Dec. 31, 2022
Summary Of Significant Accounting Policies [Line Items]
License revenue recognized		$ 0			$ 442,000
Accounting Standards Update 2021-04
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle accounting standards update, adopted						true
Change in accounting principle accounting standards update, immaterial effect						true
Merck Neuromuscular License Agreement
Summary Of Significant Accounting Policies [Line Items]
License revenue recognized		$ 0	$ 5,000,000		$ 5,000,000
Milestone payments	$ 5,000,000			$ 5,000,000
Milestones and royalties on net sales				$ 255,000,000
Maximum
Summary Of Significant Accounting Policies [Line Items]
Warrants exercise price		$ 0.14			$ 0.14